CN105560536A - 缓解疲劳的保健品组合物及其制备方法 - Google Patents
缓解疲劳的保健品组合物及其制备方法 Download PDFInfo
- Publication number
- CN105560536A CN105560536A CN201610020830.XA CN201610020830A CN105560536A CN 105560536 A CN105560536 A CN 105560536A CN 201610020830 A CN201610020830 A CN 201610020830A CN 105560536 A CN105560536 A CN 105560536A
- Authority
- CN
- China
- Prior art keywords
- halth
- preparation
- care composition
- parts
- fatigue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 230000036541 health Effects 0.000 title abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 16
- 241000208340 Araliaceae Species 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 238000010792 warming Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 6
- 235000019408 sucralose Nutrition 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 230000012010 growth Effects 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 235000011347 Moringa oleifera Nutrition 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 239000008213 purified water Substances 0.000 abstract description 3
- 240000000759 Lepidium meyenii Species 0.000 abstract 1
- 235000000421 Lepidium meyenii Nutrition 0.000 abstract 1
- 244000179886 Moringa oleifera Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 235000012902 lepidium meyenii Nutrition 0.000 abstract 1
- 235000020733 paullinia cupana extract Nutrition 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 20
- 239000013642 negative control Substances 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 230000009182 swimming Effects 0.000 description 15
- 230000037396 body weight Effects 0.000 description 13
- 102100026189 Beta-galactosidase Human genes 0.000 description 12
- 108010059881 Lactase Proteins 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 108010005774 beta-Galactosidase Proteins 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 229940116108 lactase Drugs 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 230000033001 locomotion Effects 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 229920002527 Glycogen Polymers 0.000 description 7
- 229940096919 glycogen Drugs 0.000 description 7
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 6
- 230000002440 hepatic effect Effects 0.000 description 5
- 241000220215 Moringa Species 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种缓解疲劳的保健品组合物及其制备方法,其中所述的保健品组合物按重量份数包括下述原料:人参200~500份、玛咖500~1000份、茯苓300~500份、辣木叶100~500份、瓜拉纳提取物100~300份、纯净水7179~8779份、甜味剂1份、香精20份。采用了该发明中的缓解疲劳的保健品组合物及其制备方法的有益效果在于,采用复方液体制剂,无毒副作用,缓解体力疲劳,提供工作效率,改善生活质量,本发明中的所用原料均为符合国家的相关规定,安全无毒副作用,多个方面协调作用,达到较好的缓解体疲劳的作用。
Description
技术领域
本发明涉及保健品领域,尤其涉及天然成分的保健品,具体是指一种能缓解疲劳的保健品组合物及其制备方法。
背景技术
现代生活节奏快、压力大,容易引起疲劳、倦怠、体重减轻、食欲不振、失眠、头疼、记忆力减退等症状。因此适当补充功能食品及药物对于缓解体力疲劳,提供工作效率,改善生活质量都是非常重要的。
发明内容
本发明的目的是克服了上述现有技术的缺点,提供了一种能缓解疲劳的保健品组合物及其制备方法。
为了实现上述目的,本发明的缓解疲劳的保健品组合物及其制备方法具有如下构成:
该缓解疲劳的保健品组合物,其主要特点是,所述的保健品组合物按重量份数包括下述原料:
优选地,所述的甜味剂为三氯蔗糖,所述的香精包括苹果香精及柠檬香精。
更优选地,所述的三氯蔗糖占组合物总质量的1份,苹果香精占组合物总质量的10份,柠檬香精占组合物总质量的10份。
优选地,所述的保健品组合物按重量份数包括下述原料:
进一步优选地,所述的人参为人工种植的按照医药标准炮制合格的人参,所述的玛咖为按照医药标准炮制合格的玛咖。
所述的缓解疲劳的保健品组合物的制备方法,其主要特征是,所述的制备方法包括下述步骤:
(1)将所述的人参、玛咖、茯苓,按处方称重放置煎煮锅内,第一次加水8~10倍,加热煎煮2小时,过滤;滤渣第二次加水4~6倍,加热煎煮2小时,过滤;滤渣第三次加水2~3倍,加热煎煮1.5小时,过滤;
(2)洁净环境下合并三次煎煮液,静置24h后过滤,排除不溶物,滤液供浓缩处理;
(3)洁净环境下浓缩滤液至密度为1.25;
(4)加纯净水至冷热缸中,开动搅拌器升温至65℃~70℃,加入浓缩药汁和称好的所述的瓜拉纳提取物搅拌溶解;
(5)保持冷热缸中温度,加入甜味剂搅拌溶解,最后加入香精。
优选地,所述的洁净环境为10万级洁净环境。
更优选地,所述的步骤(3)具体为:
在10万级洁净环境下,将上述净化后的滤液,浓缩压力为0.05mpa、温度为60℃,时间为12小时,浓缩至相对密度1.25左右,使药汁量和原来投入的人参、玛咖、茯苓的重量相等。
优选地,所述的制备方法在步骤(5)之后还包括:
(6)在25mpa下将搅拌后的物料过均质机,物料温度保持在70℃;
(7)升温至80℃保持恒温,灌装;
(8)灌装封口后放入杀菌柜杀菌,110℃杀菌20min,得成品。
最优选地,所述的步骤(7)具体为:
升温至80℃保持恒温,边过均质机边灌装,灌装前过120目滤网,搅拌灌装。
采用了该发明中的缓解疲劳的保健品组合物及其制备方法,其有益效果在于,采用复方液体制剂,无毒副作用,缓解体力疲劳,提供工作效率,改善生活质量,本发明中的所用原料均为符合国家的相关规定,安全无毒副作用,多个方面协调作用,达到较好的缓解体疲劳的作用。
具体实施方式
为了能够更清楚地描述本发明的技术内容,下面结合具体实施例来进行进一步的描述。
原料的功效作用:
人参的功效:富含人参皂苷,人参多糖,氨基酸,多肽,黄酮,挥发油和多种微量元素,人参对人体具有明显的抗疲劳作用、提高机体免疫,能够改善抑郁,缓解焦虑的作用。
玛咖具有药食同源的特性,在秘鲁已有5800多年食用历史,因传统上具有强身健体、提升性能力等作用。近年来在抗疲劳方面的多项研究均表明,玛咖能明显提高小鼠游泳耐力,增强小鼠在体力负荷时的承受能力和耐缺氧能力,具有显著的抗运动性疲劳作用。机理\研究发现,玛咖根中富含氨基酸、果糖、牛磺酸、矿物质锌等物质在消除运动性中枢疲劳和肌体疲劳中有重要作。
瓜拉那是亚马逊地区特产的一种野莓,内含咖啡因、维生素,以及丰富的生物碱、单宁酸、蛋白质等。其主要成份是瓜拉纳因Guaranaine,化学成份几乎等同于咖啡因,还含有可可碱和茶碱。研究显示单剂量和多剂量的瓜拉纳提取物,能增强老鼠的生理功能,增强在高压力下的生理承受力,并增强记忆力。
茯苓的功效:茯苓具有健脾养气作用,对那些久病瘦弱、食欲不振、体倦乏力、腹泻的气虚脾弱人群有扶脾益气的作用。
辣木叶的片、果荚富含多种矿物质、维生素、20种氨基酸、46种抗氧素和36种自然防炎体和矿物质。每100克的辣木中含有的维生素C是柑橘的7倍,铁是菠菜的3倍,维生素A是胡萝卜的4倍,钙质是牛奶的4倍,钾是香蕉的3倍,蛋白质是酸奶的2倍,是抗疲劳的高营养物质。
实施例一:
称取按以下重量份数:人参(人工种植)200份、玛咖500份、茯苓300份、辣木叶100份、瓜拉纳提取物100份、纯净水8779份、三氯蔗糖1、苹果香精10、柠檬香精10。将瓜拉纳、玛咖、茯苓,按处方称重放置煎煮锅内,第一次加水8倍,加热煎煮2小时,过滤;滤渣第二次加水4倍,加热煎煮2小时,过滤;滤渣第三次加水2倍,加热煎煮1.5小时,过滤。在10万级洁净环境下,合并三次煎煮液,静置24小时后,过滤,排除不溶物,滤液供浓缩处理。在10万级洁净环境下,将上述净化后的滤液,浓缩至相对密度1.25左右(浓缩压力为0.05mpa、温度为60℃,时间为12小时),药汁量和原来投入的瓜拉纳、玛咖、茯苓的重量相等。将适量纯净水注入冷热缸开动搅拌器升温至65℃,加入称好的浓缩药汁搅拌溶解,注意先预留一部分纯水溶解待加的物料。冷热缸中物料的温度控制在70℃左右,加入剩余的甜味剂搅拌溶解,最后将香精加入到冷热缸。待夹层锅的物料进入热缸后料温保持在70℃,过均质机(压力25)。物料过完均质机后搅拌升温到80℃,可以边过均质机边灌装,灌装前装120目滤网,灌装时料温保持在80℃左右,缓慢搅拌。洗瓶、灌装、封口。杀菌柜杀菌,杀菌参数:110度20分钟。得成品。
实施例二:
称取按以下重量份数:人参(人工种植)400份、玛咖1000份、茯苓500份、辣木叶300份、瓜拉纳提取物200份、纯净水7579份、三氯蔗糖1份、苹果香精10份、柠檬香精10份。将瓜拉纳、玛咖、茯苓,按处方称重放置煎煮锅内,第一次加水10倍,加热煎煮2小时,过滤;滤渣第二次加水6倍,加热煎煮2小时,过滤;滤渣第三次加水3倍,加热煎煮1.5小时,过滤。在10万级洁净环境下,合并三次煎煮液,静置24小时后,过滤,排除不溶物,滤液供浓缩处理。在10万级洁净环境下,将上述净化后的滤液,浓缩至相对密度1.25左右(浓缩压力为0.05mpa、温度为60℃,时间为12小时),药汁量和原来投入的瓜拉纳、玛咖、茯苓的重量相等。将适量纯净水注入冷热缸开动搅拌器升温至70℃,加入称好的浓缩药汁搅拌溶解,注意先预留一部分纯水溶解待加的物料。冷热缸中物料的温度控制在70℃左右,加入剩余的甜味剂搅拌溶解,最后将香精加入到冷热缸。待夹层锅的物料进入热缸后料温保持在70℃,过均质机(压力25)。物料过完均质机后搅拌升温到80℃,可以边过均质机边灌装,灌装前装120目滤网,灌装时料温保持在80℃左右,缓慢搅拌。洗瓶、灌装、封口。杀菌柜杀菌,杀菌参数:110度20分钟。得成品。
实施例三:本制剂缓解体疲劳功能试验结果
本制剂对小鼠负重游泳时间的影响:分别于实验开始、实验中期和末期,称取小鼠体重,并于实验结束时的末次灌胃30min后,置小鼠于恒温游泳箱中负重游泳。体重与负重游泳时间见表1;
表1:负重游泳试验小鼠各期体重及受试物对负重游泳时间的影响(X±SD)
注:*、**分别表示与阴性对照组相比有显著性(P<0.05)和极显著性(P<0.01)差异
试验期间各组小鼠体重均有所增加,但同期体重组间没有显著性差异,表明受试物对小鼠体重没有明显影响。小鼠负重游泳时间结果表明,三剂量组负重游泳时间明显延长,其中10倍剂量组与阴性对照组相比,差异有显著性;20倍、30倍两剂量组差异与阴性对照组相比,有极显著性(F=5.03,P=0.0052)。该结果表明,本制剂有延长小鼠负重游泳时间的作用。
本制剂对小鼠运动后血清尿素氮的影响:试验期间,小鼠三次(初始、中期和末期)体重及游泳后血清尿素氮水平的测定结果如表2;
表2:血清尿素氮试验期间小鼠体重变化及恒温游泳90min后血清尿素氮水平(X±SD)
注:*、**分别表示与阴性对照组相比有显著性(p<0.05)和极显著性(p<0.01)差异
试验期间各组小鼠体重均有所增加,但同期体重组间没有显著性差异,表明受试物对小鼠体重没有明显影响,该结果与2.1实验结果一致。小鼠游泳后血清尿素氮测定结果表明,三剂量组血清BUN明显下降,其中20倍、30倍剂量组与阴性对照组相比,差异分别具有显著性和极显著性(F=4.70,P=0.0072)。该结果表明,本制剂有降低小鼠运动后血清BUN水平的作用。
本制剂对小鼠运动后血乳酸累积与清除的影响:试验期间,小鼠三次(初始、中期和末期)体重如表3;
表3:血乳酸试验期间小鼠体重的变化(X±SD)
试验期间各组小鼠体重均有所增加,但同期体重组间没有显著性差异,表明受试物对小鼠体重没有明显影响,该结果与前两次实验结果一致。
受试物对小鼠游泳前后血乳酸水平的影响:小鼠在游泳前、游泳后及休息20min后血乳酸水平及其差值如表4;
表4:受试物对小鼠运动前后血乳酸水平的影响(X±SD,mmol/L)
注:*、**分别表示与阴性对照组相比有显著性(P<0.05)和极显著性(P<0.01)差异
由表4可见,各组小鼠运动后血乳酸水平均明显升高,经20min的休息后下降。方差分析与Q检验结果表明:(1)运动前血乳酸水平:各组间没有显著性差异(F=0.08,P=0.0244);(3)休息20分钟后血乳酸水平:5倍、20倍、30倍三剂量组明显低于阴性对照组,差异有极显著性(F=12.94,P<0.0001);(4)运动后血乳酸水平的升高幅度:5倍剂量组低于阴性对照组,差异有显著性;20倍、30倍两剂量组与阴性对照组相比,差异有极显著性(F=5.07,P=0.0050);(5)休息后血乳酸水平的降低幅度:30倍剂量组高于阴性对照组,差异有显著性(F=3.48,P=0.0258)。以上结果显示:本制剂具有减轻小鼠运动后乳酸的累积和促进乳酸清除的作用。
本制剂对小鼠肝糖原含量的影响:试验期间小鼠三次(初始、中期和末期)体重和肝糖原测定结果如表5;
表5:受试物对小鼠体重及肝糖原含量的影响(X±S)
注:*表示与阴性对照组相比有显著性(P<0.05)差异
由上表可见,试验期间各组小鼠体重均有所增加,但同期体重组间没有显著性差异,表明受试物对小鼠体重没有明显影响,该结果与前面的实验结果一致。肝糖原测定结果表明,给予受试物后,三剂量组小鼠的肝糖原含量升高,其中20、30倍两剂量组与阴性对照组相比有显著性差异(F=3.68,P=0.0207)。该结果表明,本制剂具有升高小鼠肝糖原含量的作用。
本制剂缓解体力疲劳实验结果表明:10倍剂量小鼠负重游泳时间长于阴性对照组,差异有显著性,20、30倍两剂量组与阴性对照组相比,差异有极显著性;20、30倍两剂量组小鼠游泳后血清尿素氮水平低于阴性对照组,差异分别有显著性和极显著性;5倍剂量组小鼠运动后血乳酸的升高幅度低于阴性对照组,差异有显著性,20、30倍两剂量组与阴性对照组相比,差异有显著性;30倍剂量组小鼠休息后血乳酸的降低幅度高于阴性对照组,差异有显著性;20、30倍两剂量组肝糖原含量明显高于阴性对照组,差异有显著性。
采用了该发明中的缓解疲劳的保健品组合物及其制备方法,其有益效果在于,采用复方液体制剂,无毒副作用,缓解体力疲劳,提供工作效率,改善生活质量,本发明中的所用原料均为符合国家的相关规定,安全无毒副作用,多个方面协调作用,达到较好的缓解体疲劳的作用。
在此说明书中,本发明已参照其特定的实施例作了描述。但是,很显然仍可以作出各种修改和变换而不背离本发明的精神和范围。因此,说明书应被认为是说明性的而非限制性的。
Claims (10)
1.一种缓解疲劳的保健品组合物,其特征在于,所述的保健品组合物按重量份数包括下述原料:
2.根据权利要求1所述的缓解疲劳的保健品组合物,其特征在于,所述的甜味剂为三氯蔗糖,所述的香精包括苹果香精及柠檬香精。
3.根据权利要求2所述的缓解疲劳的保健品组合物,其特征在于,所述的三氯蔗糖占组合物总质量的1份,苹果香精占组合物总质量的10份,柠檬香精占组合物总质量的10份。
4.根据权利要求1所述的缓解疲劳的保健品组合物,其特征在于,所述的保健品组合物按重量份数包括下述原料:
5.根据权利要求1所述的缓解疲劳的保健品组合物,其特征在于,所述的人参为人工种植的按照医药标准炮制合格的人参,所述的玛咖为按照医药标准炮制合格的玛咖。
6.根据权利要求1所述的缓解疲劳的保健品组合物的制备方法,其特征在于,所述的制备方法包括下述步骤:
(1)将所述的人参、玛咖、茯苓,按处方称重放置煎煮锅内,第一次加水8~10倍,加热煎煮2小时,过滤;滤渣第二次加水4~6倍,加热煎煮2小时,过滤;滤渣第三次加水2~3倍,加热煎煮1.5小时,过滤;
(2)洁净环境下合并三次煎煮液,静置24h后过滤,排除不溶物,滤液供浓缩处理;
(3)洁净环境下浓缩滤液至密度为1.25;
(4)加纯净水至冷热缸中,开动搅拌器升温至65℃~70℃,加入浓缩药汁和称好的所述的瓜拉纳提取物搅拌溶解;
(5)保持冷热缸中温度,加入甜味剂搅拌溶解,最后加入香精。
7.根据权利要求6所述的缓解疲劳的保健品组合物的制备方法,其特征在于,所述的洁净环境为10万级洁净环境。
8.根据权利要求6所述的缓解疲劳的保健品组合物的制备方法,其特征在于,所述的步骤(3)具体为:
在10万级洁净环境下,将上述净化后的滤液,浓缩压力为0.05mpa、温度为60℃,时间为12小时,浓缩至相对密度1.25左右,使药汁量和原来投入的人参、玛咖、茯苓的重量相等。
9.根据权利要求6所述的缓解疲劳的保健品组合物的制备方法,其特征在于,所述的制备方法在步骤(5)之后还包括:
(6)在25mpa下将搅拌后的物料过均质机,物料温度保持在70℃;
(7)升温至80℃保持恒温,灌装;
(8)灌装封口后放入杀菌柜杀菌,110℃杀菌20min,得成品。
10.根据权利要求9所述的缓解疲劳的保健品组合物的制备方法,其特征在于,所述的步骤(7)具体为:
升温至80℃保持恒温,边过均质机边灌装,灌装前过120目滤网,搅拌灌装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610020830.XA CN105560536A (zh) | 2016-01-13 | 2016-01-13 | 缓解疲劳的保健品组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610020830.XA CN105560536A (zh) | 2016-01-13 | 2016-01-13 | 缓解疲劳的保健品组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105560536A true CN105560536A (zh) | 2016-05-11 |
Family
ID=55871549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610020830.XA Pending CN105560536A (zh) | 2016-01-13 | 2016-01-13 | 缓解疲劳的保健品组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105560536A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574140A (zh) * | 2008-11-27 | 2009-11-11 | 厦门金日制药有限公司 | 一种具有增强人体免疫功能和抗疲劳作用的饮品组合物 |
CN102078021A (zh) * | 2010-12-09 | 2011-06-01 | 何伟 | 功能性保健饮料 |
CN102919845A (zh) * | 2012-11-21 | 2013-02-13 | 济南老来寿生物股份有限公司 | 一种缓解体力疲劳的保健食品 |
CN104366647A (zh) * | 2014-10-20 | 2015-02-25 | 北京康比特体育科技股份有限公司 | 一种增强耐力、缓解疲劳的组合物及其制备方法 |
CN104825791A (zh) * | 2015-04-27 | 2015-08-12 | 湖北金鹰生物科技有限公司 | 一种具有抗疲劳功能的中药保健品及其制备方法 |
-
2016
- 2016-01-13 CN CN201610020830.XA patent/CN105560536A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574140A (zh) * | 2008-11-27 | 2009-11-11 | 厦门金日制药有限公司 | 一种具有增强人体免疫功能和抗疲劳作用的饮品组合物 |
CN102078021A (zh) * | 2010-12-09 | 2011-06-01 | 何伟 | 功能性保健饮料 |
CN102919845A (zh) * | 2012-11-21 | 2013-02-13 | 济南老来寿生物股份有限公司 | 一种缓解体力疲劳的保健食品 |
CN104366647A (zh) * | 2014-10-20 | 2015-02-25 | 北京康比特体育科技股份有限公司 | 一种增强耐力、缓解疲劳的组合物及其制备方法 |
CN104825791A (zh) * | 2015-04-27 | 2015-08-12 | 湖北金鹰生物科技有限公司 | 一种具有抗疲劳功能的中药保健品及其制备方法 |
Non-Patent Citations (1)
Title |
---|
盛军: "《现代辣木生物学》", 31 January 2015, 云南科技出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100340651C (zh) | 一种大鲵保健酒及制备方法 | |
CN101543569B (zh) | 一种阿胶滋养膏及其制备方法 | |
CN101642176A (zh) | 一种缓解神经衰弱的酸枣蜂蜜茶的制作方法 | |
CN109266485A (zh) | 一种保健酒及其制备方法 | |
CN104928140A (zh) | 一种复合发酵型冬枣保健酒及其生产工艺 | |
CN102787057A (zh) | 养生保健酒及其制备方法 | |
CN103478295B (zh) | 一种补钙保健葡萄籽油 | |
CN105876439A (zh) | 一种用于增强免疫力和抗疲劳的中药保健品及其制备方法 | |
CN105560536A (zh) | 缓解疲劳的保健品组合物及其制备方法 | |
CN110326697A (zh) | 一种用于治疗失眠的酸枣仁膏及其制备方法 | |
CN101684445A (zh) | 一种鹿茸血酒及其加工方法 | |
CN105969612A (zh) | 一种辣木籽保健酒 | |
CN104971295B (zh) | 一种中药组合物及其在制备羊栖菜莲子营养酒中的应用 | |
CN100356967C (zh) | 芦苓保健醋及其制备方法 | |
CN104489842B (zh) | 红小豆玫瑰营养饮料及其制备方法 | |
CN106234889A (zh) | 一种石榴西番莲蜂蜜饮料及其制作方法 | |
CN102160639B (zh) | 一种具有健脑益智功能的保健食品 | |
CN103584214A (zh) | 一种虫草山楂汁饮料 | |
CN1075732C (zh) | 健脑降血脂口服液 | |
CN1887332A (zh) | 一种增强免疫力的地黄茶颗粒及其配制工艺方法 | |
CN106473124A (zh) | 一种促进婴幼儿智力发育的组合物 | |
CN108504512A (zh) | 一种蛹虫草保健药酒及其制备方法 | |
CN106261255A (zh) | 一种红枣西番莲蜂蜜饮料及其制作方法 | |
CN106173688A (zh) | 一种金珠果西番莲蜂蜜饮料及其制作方法 | |
CN106923330A (zh) | 一种梨子的腌制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160511 |
|
WD01 | Invention patent application deemed withdrawn after publication |